WG
XBIT icon

Winton Group’s XBiotech XBIT Stock Holding History

Winton Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,124
Closed -$274K – 1442
2021
Q3 		$274K Buy
21,124
+2,501
+13% +$39.8K 0.02% 1131
2021
Q2 		$308K Buy
18,623
+2,250
+14% +$38.2K 0.02% 1167
2021
Q1 		$281K Buy
16,373
+3,154
+24% +$58.9K 0.02% 1170
2020
Q4 		$207K Sell
13,219
-21,597
-62% -$398K 0.01% 1182
2020
Q3 		$665K Buy
34,816
+2,662
+8% +$45.9K 0.02% 991
2020
Q2 		$441K Buy
+32,154
New +$452K 0.01% 1209
2019
Q4 		– Sell
-34,022
Closed -$356K – 1787
2019
Q3 		$356K Buy
+34,022
New +$277K ﹤0.01% 1208

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winton Group's XBIT Position: Q4 2021 in Review

Winton Group sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 21,124 shares — an estimated $274K sold.

Winton Group first reported a position in XBIT in Q3 2019 and held it in 7 quarters. The position peaked at $665K in Q3 2020. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • Winton Group reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 21,124 XBiotech shares in Q4 2021, an estimated $274K.
  • Winton Group first reported a position in XBiotech in Q3 2019 and held it in 7 quarters.
  • Winton Group's XBiotech position peaked at $665K in Q3 2020.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.